Arcus Biosciences's total assets for Q2 2025 were $1.07B, a decrease of -7.01% from the previous quarter. RCUS total liabilities were $526.00M for the fiscal quarter, a -15.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.